Literature DB >> 1331504

Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing.

J McLauchlan1, A Phelan, C Loney, R M Sandri-Goldin, J B Clements.   

Abstract

We have shown previously that a novel herpes simplex virus-induced activity, LPF, selectively increases RNA 3'-end processing at the poly(A) site of a late virus gene (J. McLauchlan, S. Simpson, and J. B. Clements, Cell 59:1093-1105, 1989). Here, our in vivo and in vitro analyses both demonstrate that LPF is induced during early stages of virus infection. Studies of virus mutants indicate that expression of the immediate-early IE63 gene is required for induction of this activity. The selective effects on 3' processing displayed in the presence of IE63 provide direct evidence that IE63 can influence this posttranscription process. This extends previous studies which reported increases in reporter gene activity with certain poly(A) sites by IE63 (R. M. Sandri-Goldin and G. E. Mendoza, Genes Dev. 6:848-863, 1992).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331504      PMCID: PMC240324     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing.

Authors:  R M Sandri-Goldin; G E Mendoza
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

2.  A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Insertion of DNA sequences at a unique restriction enzyme site engineered for vector purposes into the genome of herpes simplex virus type 1.

Authors:  F J Rixon; J McLauchlan
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

4.  The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection.

Authors:  L McMahan; P A Schaffer
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

5.  Identification of the genes encoding two capsid proteins of herpes simplex virus type 1 by direct amino acid sequencing.

Authors:  F J Rixon; M D Davison; A J Davison
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

6.  Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

8.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

9.  A single amino acid substitution in the large subunit of herpes simplex virus type 1 ribonucleotide reductase which prevents subunit association.

Authors:  I Nikas; A J Darling; H M Lankinen; A M Cross; H S Marsden; J B Clements
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

10.  Promoter-independent activation of heterologous virus gene expression by the herpes simplex virus immediate-early protein ICP27.

Authors:  C J Chapman; J D Harris; M A Hardwicke; R M Sandri-Goldin; M K Collins; D S Latchman
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  77 in total

1.  Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated alpha-globin pre-mRNA in infected HeLa cells.

Authors:  P Cheung; K S Ellison; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways.

Authors:  T M Soliman; S J Silverstein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Processing of alpha-globin and ICP0 mRNA in cells infected with herpes simplex virus type 1 ICP27 mutants.

Authors:  K S Ellison; S A Rice; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway.

Authors:  M D Koffa; J B Clements; E Izaurralde; S Wadd; S A Wilson; I W Mattaj; S Kuersten
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

5.  ICP27 selectively regulates the cytoplasmic localization of a subset of viral transcripts in herpes simplex virus type 1-infected cells.

Authors:  Angela Pearson; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Authors:  C R Brown; M S Nakamura; J D Mosca; G S Hayward; S E Straus; L P Perera
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II.

Authors:  Kathryn A Fraser; Stephen A Rice
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.

Authors:  M Winkler; S A Rice; T Stamminger
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.